Skip to main content

Sumitomo Dainippon Pharma Value Stock - Dividend - Research Selection

Sumitomo Dainippon Pharma Co., Ltd.

ISIN: JP3495000006, WKN: 858257

Market price date: 22.01.2021
Market price: 1.511,00 JPY

Sumitomo Dainippon Pharma Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 25-05-2020
Cash flow
Net operating cash flow
Capital Expenditures -13.351.000.000
Free cash flow 32.777.000.960
Balance sheet
Total Equity 632.105.000.000
Liabilities & Shareholders equity 1.252.880.000.000
Income statement
Net income 40.753.000.000
Eps (diluted) 102,580
Diluted shares outstanding 397.280.000
Net sales/revenue 482.732.000.000

Fundamental ratios calculated on: 22-01-2021

Key figures 22-01-2021
Cash flow
P/C 13,01
P/FC 18,31
Balance sheet
Income statement
Div. Yield1,85%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization5.787.490.304,00 USD
IndicesNIKKEI 225
Raw Data SourceIFRS in Millionen JPY
Stock Split

Description of the company

The Sumitomo Dainippon Pharma Group represents the pharmaceutical business as its core activity, but also engages in other activities that include food ingredients, food additives and chemical product materials, animal health products, diagnostics and research materials.


To deliver innovative and beneficial medicines to people around the world and also in Japan, we are committed to using advanced research and development for all of our new medicines. With the goal of improving customer satisfaction, we also provide all relevant information about our drug products.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,